To mesh or not to mesh: a review of pelvic organ reconstructive surgery
- PMID: 25848324
- PMCID: PMC4386830
- DOI: 10.2147/IJWH.S71236
To mesh or not to mesh: a review of pelvic organ reconstructive surgery
Abstract
Pelvic organ prolapse (POP) is a major health issue with a lifetime risk of undergoing at least one surgical intervention estimated at close to 10%. In the 1990s, the risk of reoperation after primary standard vaginal procedure was estimated to be as high as 30% to 50%. In order to reduce the risk of relapse, gynecological surgeons started to use mesh implants in pelvic organ reconstructive surgery with the emergence of new complications. Recent studies have nevertheless shown that the risk of POP recurrence requiring reoperation is lower than previously estimated, being closer to 10% rather than 30%. The development of mesh surgery - actively promoted by the marketing industry - was tremendous during the past decade, and preceded any studies supporting its benefit for our patients. Randomized trials comparing the use of mesh to native tissue repair in POP surgery have now shown better anatomical but similar functional outcomes, and meshes are associated with more complications, in particular for transvaginal mesh implants. POP is not a life-threatening condition, but a functional problem that impairs quality of life for women. The old adage "primum non nocere" is particularly appropriate when dealing with this condition which requires no treatment when asymptomatic. It is currently admitted that a certain degree of POP is physiological with aging when situated above the landmark of the hymen. Treatment should be individualized and the use of mesh needs to be selective and appropriate. Mesh implants are probably an important tool in pelvic reconstructive surgery, but the ideal implant has yet to be found. The indications for its use still require caution and discernment. This review explores the reasons behind the introduction of mesh augmentation in POP surgery, and aims to clarify the risks, benefits, and the recognized indications for its use.
Keywords: mesh implants; mesh surgery; pelvic floor; pelvic organ prolapse surgery; review.
Figures
Similar articles
-
[Vaginal reconstruction for the remedy of pelvic organ prolapse: the effect, influence on urinary and sexual function and quality of life in two-years follow-upPart I. Vaginal status and complications].Ceska Gynekol. 2017 Winter;82(6):430-435. Ceska Gynekol. 2017. PMID: 29302975 Czech.
-
Attachment of Primary Vaginal Fibroblasts to Absorbable and Nonabsorbable Implant Materials Coated With Platelet-Rich Plasma: Potential Application in Pelvic Organ Prolapse Surgery.Female Pelvic Med Reconstr Surg. 2015 Jul-Aug;21(4):190-7. doi: 10.1097/SPV.0000000000000178. Female Pelvic Med Reconstr Surg. 2015. PMID: 25900058
-
Tissue response to collagen containing polypropylene meshes in an ovine vaginal repair model.Acta Biomater. 2016 Jul 15;39:114-123. doi: 10.1016/j.actbio.2016.05.010. Epub 2016 May 6. Acta Biomater. 2016. PMID: 27163402
-
Vaginal Approaches Using Synthetic Mesh to Treat Pelvic Organ Prolapse.Ann Coloproctol. 2016 Feb;32(1):7-11. doi: 10.3393/ac.2016.32.1.7. Epub 2016 Feb 29. Ann Coloproctol. 2016. PMID: 26962530 Free PMC article. Review.
-
[Implants for genital prolapse : Contra mesh surgery].Urologe A. 2017 Dec;56(12):1583-1590. doi: 10.1007/s00120-017-0525-y. Urologe A. 2017. PMID: 29119201 Review. German.
Cited by
-
Characterization in respect to degradation of titanium-coated polypropylene surgical mesh explanted from humans.J Biomed Mater Res B Appl Biomater. 2023 May;111(5):1142-1152. doi: 10.1002/jbm.b.35221. Epub 2023 Jan 7. J Biomed Mater Res B Appl Biomater. 2023. PMID: 36610021 Free PMC article.
-
Native-tissue repair of isolated primary rectocele compared with nonabsorbable mesh: patient-reported outcomes.Int Urogynecol J. 2017 Jan;28(1):49-57. doi: 10.1007/s00192-016-3072-y. Epub 2016 Jul 5. Int Urogynecol J. 2017. PMID: 27379892
-
Effectiveness and Safety of Posterior Vaginal Repair with Single-Incision, Ultralightweight, Monofilament Propylene Mesh: First Evidence from a Case Series with Short-Term Results.Biomed Res Int. 2021 Jan 2;2021:3204145. doi: 10.1155/2021/3204145. eCollection 2021. Biomed Res Int. 2021. PMID: 33490268 Free PMC article.
-
The Manchester procedure: anatomical, subjective and sexual outcomes.Int Urogynecol J. 2018 Aug;29(8):1193-1201. doi: 10.1007/s00192-018-3622-6. Epub 2018 Mar 12. Int Urogynecol J. 2018. PMID: 29532126
-
Initial Experience of Laparoscopic Pectopexy for Apical Prolapse in South Korea.J Menopausal Med. 2020 Dec;26(3):165-168. doi: 10.6118/jmm.20029. J Menopausal Med. 2020. PMID: 33423405 Free PMC article.
References
-
- Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501–506. - PubMed
-
- Fialkow MF, Newton KM, Lentz GM, Weiss NS. Lifetime risk of surgical management for pelvic organ prolapse or urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:437–440. - PubMed
-
- Clark AL, Gregory T, Smith VJ, Edwards R. Epidemiologic evaluation of reoperation for surgically treated pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol. 2003;189(5):1261–1267. - PubMed
-
- Whiteside JL, Weber AM, Meyn LA, Walters MD. Risk factors for prolapse recurrence after vaginal repair. Am J Obstet Gynecol. 2004;191(5):1533–1538. - PubMed
-
- Jakus SM, Shapiro A, Hall CD. Biologic and synthetic graft use in pelvic surgery: a review. Obstet Gynecol Surv. 2008;63(4):253–266. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous